Baby gestational diabetes Type 2 diabetes mellitus - previously known as adult-onset diabetes, maturity-onset diabetes, or non-insulin dependent diabetes mellitus (NIDDM) - is due to a bination of defective insulin secretion and defective responsiveness to insulin (often termed insulin resistance or reduced insulin sensitivity), almost certainly involving the insulin receptor in cell membranes. Cesarian section may be preformed if there is marked fetal distress, or an increased risk of injury associated with macrosomia such as shoulder dystocia. The onset of the disease is most mon in middle age and later life. Type 1 diabetes (formerly known as "childhood" or "juvenile" diabetes or "insulin dependent" diabetes) is most monly diagnosed in children and adolescents. "Insights from the diabetes control and plications trial/epidemiology of diabetes interventions and plications study on the use of intensive glycemic treatment to reduce the risk of plications of type 1 diabetes.". The liver is expected to be the most reasonable choice because it is more accessible than the pancreas and the Islet cells seem to produce insulin well in that environment. Baby gestational diabetes. Diabetes gestational prevention
In severe cases perinatal death may occur, most monly as a result of poor placental profusion due to vascular impairment. Baby gestational diabetes. Diabetes mellitus occurs throughout the world, but is more mon (especially type 2) in the more developed countries. The classical triad of diabetes symptoms is polyuria (frequent urination), polydipsia (increased thirst, and consequent increased fluid intake) and polyphagia (increased appetite). The classification, or type, of diabetes is determined by the underlying cause of the diabetes, not the type of therapy that is used to treat the diabetes. Knowledgeable patient participation is vital and so patient education is a crucial aspect of this effort. Knowledgeable patient participation is vital and so patient education is a crucial aspect of this effort. The most useful laboratory test to distinguish Type 1 from Type 2 diabetes is the C-peptide assay, which is a measure of endogenous insulin production since external insulin to date has included no C-peptide. The fraction of type 2 diabetics in other parts of the world varies substantially, almost certainly for environmental and lifestyle reasons, though these are not known in detail. The term non-insulin-dependent diabetes is thus inaccurate and misleading. |